Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Expert Opinion on Emerging Drugs|November 9, 2016
Emerging biological therapies to treat acute lymphoblastic leukemiaFrançoise Huguet, Suzanne TavitianCurrent Hematologic Malignancy Reports|April 1, 2014
Pediatric-like therapy for adults with ALLHervé Dombret, Thomas Cluzeau, Françoise Huguet, et al.Pharmacy World & Science : PWS|April 9, 2008
Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphomaFranck Laporte, Safouane Hamdi, Françoise Oksman, et al.Expert Review of Hematology|July 10, 2023
Dose optimisation of ponatinib in chronic phase chronic myeloid leukemiaFrançoise Huguet, Delphine Réa, Emilie Cayssials, et al.Case Reports in Hematology|December 13, 2019
Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult PatientGuillaume Beziat, Suzanne Tavitian, Muriel Picard, et al.Cancer Chemotherapy and Pharmacology|November 28, 2012
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?Peggy Gandia, Cécile Arellano, Thierry Lafont, et al.Frontiers in Oncology|October 18, 2021
Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in FranceMarie Pajiep, Cécile Conte, Françoise Huguet, et al.Cancers|August 26, 2023
A Multicenter Retrospective Chart Review Study of Treatment and Disease Patterns and Clinical Outcomes of Patients with Chronic-Phase Chronic Myeloid Leukemia in Third-Line Treatment or with T315I MutationFranck-Emmanuel Nicolini, Françoise Huguet, Lynn Huynh, et al.Leukemia & Lymphoma|July 6, 2014
Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroupFrançoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.Pageof 12